![Product Image](https://www.skfbd.com/uploads/medicine/details_thumb/62e113538a1ac.20220727.jpg)
![Product Image](https://www.skfbd.com/uploads/medicine/details_thumb/62e11353d3c77.20220727.jpg)
![Product Image](https://www.skfbd.com/uploads/medicine/details_thumb/62e113540b55a.20220727.jpg)
![Product Image](https://www.skfbd.com/uploads/medicine/listing_thumb/62e113538a1ac.20220727.jpg)
![Product Image](https://www.skfbd.com/uploads/medicine/listing_thumb/62e11353d3c77.20220727.jpg)
![Product Image](https://www.skfbd.com/uploads/medicine/listing_thumb/62e113540b55a.20220727.jpg)
Aladay DS
DESCRIPTION
Aladay® & Aladay® DS are preparations of Olopatadine. Olopatadine is an anti-allergic compound which has been demonstrated to stabilize human
conjunctival tissue mast cells, preventing the release of histamine and other inflammatory mediators. Olopatadine is a selective histamine H1-antagonist that inhibits Type I immediate hypersensitivity reactions. It has been shown to inhibit the release of pro-inflammatory mediators from human conjunctival mast and epithelial cells. Olopatadine has no significant effects on alpha-adrenergic, dopamine and muscarinic Type 1 and 2 receptors.